Last 12 months
Inside the activity.
1 purchase rows · 42 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 12 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 11 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 1 | 6 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2019 Filed Mar 18, 2019 21:25 UTC |
Hassan FredDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 42,450 | $0.00 Strike: $5.06 | $0.00 |
DisclosureSEC source: 0001123292-19-000526 · edgar.xml · derivative · entry 3 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,450 Underlying: Common Stock · 42,450 shares Expires 2029-03-08 Read SEC document |
| March 08, 2019 Filed Mar 18, 2019 21:25 UTC |
Hassan FredDirector
|
GrantRestricted Stock Units · Derivative | 24,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000526 · edgar.xml · derivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,614 Underlying: Common Stock · 24,703 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vest in full one year from the grant date. F3 · derivative.expiration_date: The restricted stock units vest in full one year from the grant date. Read SEC document |
| March 08, 2019 Filed Mar 18, 2019 21:25 UTC |
Hassan FredDirector
|
GrantCommon Stock | 11,166 | $5.06 | $56,499.96 |
DisclosureSEC source: 0001123292-19-000526 · edgar.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,447 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $56,500. Read SEC document |
| March 06, 2019 Filed Mar 7, 2019 02:07 UTC |
Bostick ThomasChief Operating Officer
|
GrantCommon Stock | 2,075 | $4.86 | $10,084.50 |
DisclosureSEC source: 0001123292-19-000443 · edgar.xml · nonDerivative · entry 1 Bostick Thomas · CIK 0001724193 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,895 Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 02:07 UTC |
Reed Thomas D.Chief Science Officer
|
SaleCommon Stock | 2,300 | $4.66 | $10,718.00 |
DisclosureSEC source: 0001123292-19-000444 · edgar.xml · nonDerivative · entry 4 Reed Thomas D. · CIK 0001583188 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By trust of spouse Disclosed balance after: 41,705 F1 · kind: Sale undertaken by reporting person's lender to whom the shares were pledged. F3 · ownership.nature: Held by the Jacquelyn Ann Reed Living Trust dated February 4, 2011. Read SEC document |
| March 04, 2019 Filed Mar 7, 2019 02:07 UTC |
Reed Thomas D.Chief Science Officer
|
SaleCommon Stock | 44,000 | $4.22 | $185,680.00 |
DisclosureSEC source: 0001123292-19-000444 · edgar.xml · nonDerivative · entry 3 Reed Thomas D. · CIK 0001583188 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By trust of spouse Disclosed balance after: 44,005 F1 · kind: Sale undertaken by reporting person's lender to whom the shares were pledged. F3 · ownership.nature: Held by the Jacquelyn Ann Reed Living Trust dated February 4, 2011. Read SEC document |
| March 04, 2019 Filed Mar 7, 2019 02:07 UTC |
Reed Thomas D.Chief Science Officer
|
SaleCommon Stock | 165,000 | $4.17 | $688,050.00 |
DisclosureSEC source: 0001123292-19-000444 · edgar.xml · nonDerivative · entry 2 Reed Thomas D. · CIK 0001583188 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By trust of spouse Disclosed balance after: 88,005 F1 · kind: Sale undertaken by reporting person's lender to whom the shares were pledged. F3 · ownership.nature: Held by the Jacquelyn Ann Reed Living Trust dated February 4, 2011. Read SEC document |
| March 04, 2019 Filed Mar 7, 2019 02:07 UTC |
Reed Thomas D.Chief Science Officer
|
SaleCommon Stock | 16,500 | $4.24 | $69,960.00 |
DisclosureSEC source: 0001123292-19-000444 · edgar.xml · nonDerivative · entry 1 Reed Thomas D. · CIK 0001583188 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 62,840 F1 · kind: Sale undertaken by reporting person's lender to whom the shares were pledged. F2 · ownership.nature: Held by the Thomas David Reed Living Trust dated February 4, 2011. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 16:33 UTC |
KIRK RANDAL JDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 25,094 | $7.97 | $199,999.18 |
DisclosureSEC source: 0001567619-19-005801 · doc1.xml · nonDerivative · entry 1 KIRK RANDAL J · CIK 0001091823 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by R.J. Kirk DOT Disclosed balance after: 16,108,845 F1 · shares: In accordance with the Restricted Stock Unit Agreement dated November 1, 2015 between Intrexon and Randal J. Kirk, each month Mr. Kirk will receive that number of shares of Intrexon common stock, rounded down to the nearest whole share, whose fair market value equals $200,000. The number of shares of Intrexon common stock are to become vested and payable based upon the closing price of the common stock of Intrexon on the NYSE on the last calendar day of each month (or, if such date is not a trading day, the most recent trading day prior to such date). Mr. Kirk has designated the R.J. Kirk Declaration of Trust ("R.J. Kirk DOT") to receive these shares. F1 · price: In accordance with the Restricted Stock Unit Agreement dated November 1, 2015 between Intrexon and Randal J. Kirk, each month Mr. Kirk will receive that number of shares of Intrexon common stock, rounded down to the nearest whole share, whose fair market value equals $200,000. The number of shares of Intrexon common stock are to become vested and payable based upon the closing price of the common stock of Intrexon on the NYSE on the last calendar day of each month (or, if such date is not a trading day, the most recent trading day prior to such date). Mr. Kirk has designated the R.J. Kirk Declaration of Trust ("R.J. Kirk DOT") to receive these shares. F2 · ownership.nature: Randal J. Kirk controls each of R.J. Kirk DOT, Third Security, LLC ("Third Security"), JPK 2008, LLC ("JPK 2008"), JPK 2009, LLC ("JPK 2009"), JPK 2012, LLC ("JPK 2012"), Kellie L. Banks (2009) Long Term Trust ("Kellie L. Banks LTT"), MGK 2008, LLC ("MGK 2008"), MGK 2009, LLC ("MGK 2009"), MGK 2011, LLC ("MGK 2011"), Third Security Senior Staff 2015 LLC ("Sr. Staff 2015"), Third Security Staff 2015 LLC ("Staff 2015"), ZSK 2008, LLC ("ZSK 2008"), ZSK 2009, LLC ("ZSK 2009"), and Kapital Joe, LLC ("Kapital Joe"). Shares held by these entities may be deemed to be beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:46 UTC |
ALVAREZ CESAR LDirector
|
Exercise / conversionOption to Purchase Common Stock (Right to Buy) · Derivative | 2,968 | $0.00 Strike: $3.17 | $0.00 |
DisclosureSEC source: 0001123292-19-000307 · edgar.xml · derivative · entry 2 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,968 shares Expires 2019-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was immediately exercisable. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:46 UTC |
ALVAREZ CESAR LDirector
|
Exercise / conversionCommon Stock | 2,968 | $3.17 | $9,408.56 |
DisclosureSEC source: 0001123292-19-000307 · edgar.xml · nonDerivative · entry 1 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:41 UTC |
Frank StevenDirector
|
Exercise / conversionOption to Purchase Common Stock (Right to Buy) · Derivative | 2,968 | $0.00 Strike: $3.17 | $0.00 |
DisclosureSEC source: 0001123292-19-000260 · edgar.xml · derivative · entry 2 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,968 shares Expires 2019-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was immediately exercisable. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:41 UTC |
Frank StevenDirector
|
Exercise / conversionCommon Stock | 2,968 | $3.17 | $9,408.56 |
DisclosureSEC source: 0001123292-19-000260 · edgar.xml · nonDerivative · entry 1 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 21:57 UTC |
Reed Thomas D.Chief Science Officer
|
Exercise / conversionOption to Purchase Common Stock (Right to Buy) · Derivative | 2,969 | $0.00 Strike: $3.17 | $0.00 |
DisclosureSEC source: 0001123292-19-000231 · edgar.xml · derivative · entry 2 Reed Thomas D. · CIK 0001583188 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,969 shares Expires 2019-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was immediately exercisable. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 21:57 UTC |
Reed Thomas D.Chief Science Officer
|
Exercise / conversionCommon Stock | 2,969 | $3.17 | $9,411.73 |
DisclosureSEC source: 0001123292-19-000231 · edgar.xml · nonDerivative · entry 1 Reed Thomas D. · CIK 0001583188 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 19:07 UTC |
KIRK RANDAL JDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 26,109 | $7.66 | $199,994.94 |
DisclosureSEC source: 0001567619-19-002293 · doc1.xml · nonDerivative · entry 1 KIRK RANDAL J · CIK 0001091823 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by R.J. Kirk DOT Disclosed balance after: 16,083,751 F1 · shares: In accordance with the Restricted Stock Unit Agreement dated November 1, 2015 between Intrexon and Randal J. Kirk, each month Mr. Kirk will receive that number of shares of Intrexon common stock, rounded down to the nearest whole share, whose fair market value equals $200,000. The number of shares of Intrexon common stock are to become vested and payable based upon the closing price of the common stock of Intrexon on the NYSE on the last calendar day of each month (or, if such date is not a trading day, the most recent trading day prior to such date). Mr. Kirk has designated the R.J. Kirk Declaration of Trust ("R.J. Kirk DOT") to receive these shares. F1 · price: In accordance with the Restricted Stock Unit Agreement dated November 1, 2015 between Intrexon and Randal J. Kirk, each month Mr. Kirk will receive that number of shares of Intrexon common stock, rounded down to the nearest whole share, whose fair market value equals $200,000. The number of shares of Intrexon common stock are to become vested and payable based upon the closing price of the common stock of Intrexon on the NYSE on the last calendar day of each month (or, if such date is not a trading day, the most recent trading day prior to such date). Mr. Kirk has designated the R.J. Kirk Declaration of Trust ("R.J. Kirk DOT") to receive these shares. F2 · ownership.nature: Randal J. Kirk controls each of R.J. Kirk DOT, Third Security, LLC ("Third Security"), JPK 2008, LLC ("JPK 2008"), JPK 2009, LLC ("JPK 2009"), JPK 2012, LLC ("JPK 2012"), Kellie L. Banks (2009) Long Term Trust ("Kellie L. Banks LTT"), MGK 2008, LLC ("MGK 2008"), MGK 2009, LLC ("MGK 2009"), MGK 2011, LLC ("MGK 2011"), Third Security Senior Staff 2015 LLC ("Sr. Staff 2015"), Third Security Staff 2015 LLC ("Staff 2015"), ZSK 2008, LLC ("ZSK 2008"), ZSK 2009, LLC ("ZSK 2009"), and Kapital Joe, LLC ("Kapital Joe"). Shares held by these entities may be deemed to be beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 22:31 UTC |
Sabzevari HelenPresident, Precigen, Inc.
|
GrantRestricted Stock Units · Derivative | 56,891 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000206 · edgar.xml · derivative · entry 1 Sabzevari Helen · CIK 0001724195 · President, Precigen, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,666 Underlying: Common Stock · 56,891 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. Read SEC document |
| January 04, 2019 Filed Jan 4, 2019 18:46 UTC |
LIFFMAN JOEL DSVP, Finance
|
SaleCommon Stock | 3,725 | $7.03 | $26,186.75 |
DisclosureSEC source: 0001123292-19-000081 · edgar.xml · nonDerivative · entry 2 LIFFMAN JOEL D · CIK 0001093734 · SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,541 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 20:08 UTC |
LIFFMAN JOEL DSVP, Finance
|
GrantRestricted Stock Units · Derivative | 75,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000132 · edgar.xml · derivative · entry 2 LIFFMAN JOEL D · CIK 0001093734 · SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,758 Underlying: Common Stock · 75,758 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 20:08 UTC |
LIFFMAN JOEL DSVP, Finance
|
GrantCommon Stock | 13,774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000132 · edgar.xml · nonDerivative · entry 1 LIFFMAN JOEL D · CIK 0001093734 · SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,315 F1 · price: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 21:34 UTC |
KIRK RANDAL JDirector · Chief Executive Officer · 10% owner
|
GrantRestricted Stock Units · Derivative | 13,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-000837 · doc1.xml · derivative · entry 29 KIRK RANDAL J · CIK 0001091823 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by R.J. Kirk DOT Disclosed balance after: 13,775 Underlying: Common Stock · 13,775 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest in four (4) equal annual installments beginning January 4, 2020. F3 · derivative.expiration_date: The restricted stock units vest in four (4) equal annual installments beginning January 4, 2020. F4 · ownership.nature: Randal J. Kirk controls each of R.J. Kirk Declaration of Trust ("R.J. Kirk DOT"), Third Security, LLC ("Third Security"), JPK 2008, LLC ("JPK 2008"), JPK 2009, LLC ("JPK 2009"), JPK 2012, LLC ("JPK 2012"), Kellie L. Banks (2009) Long Term Trust ("Kellie L. Banks LTT"), MGK 2008, LLC ("MGK 2008"), MGK 2009, LLC ("MGK 2009"), MGK 2011, LLC ("MGK 2011"), Third Security Senior Staff 2015 LLC ("Sr. Staff 2015"), Third Security Staff 2015 LLC ("Staff 2015"), ZSK 2008, LLC ("ZSK 2008"), ZSK 2009, LLC ("ZSK 2009"), and Kapital Joe, LLC ("Kapital Joe"). Shares held by these entities may be deemed to be beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 21:34 UTC |
KIRK RANDAL JDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 13,774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-19-000837 · doc1.xml · nonDerivative · entry 1 KIRK RANDAL J · CIK 0001091823 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by R.J. Kirk DOT Disclosed balance after: 16,057,642 F1 · price: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation. F4 · ownership.nature: Randal J. Kirk controls each of R.J. Kirk Declaration of Trust ("R.J. Kirk DOT"), Third Security, LLC ("Third Security"), JPK 2008, LLC ("JPK 2008"), JPK 2009, LLC ("JPK 2009"), JPK 2012, LLC ("JPK 2012"), Kellie L. Banks (2009) Long Term Trust ("Kellie L. Banks LTT"), MGK 2008, LLC ("MGK 2008"), MGK 2009, LLC ("MGK 2009"), MGK 2011, LLC ("MGK 2011"), Third Security Senior Staff 2015 LLC ("Sr. Staff 2015"), Third Security Staff 2015 LLC ("Staff 2015"), ZSK 2008, LLC ("ZSK 2008"), ZSK 2009, LLC ("ZSK 2009"), and Kapital Joe, LLC ("Kapital Joe"). Shares held by these entities may be deemed to be beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:08 UTC |
Lehr Donald P.Chief Legal Officer
|
GrantRestricted Stock Units · Derivative | 75,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000133 · edgar.xml · derivative · entry 2 Lehr Donald P. · CIK 0001583187 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,758 Underlying: Common Stock · 75,758 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:08 UTC |
Lehr Donald P.Chief Legal Officer
|
GrantCommon Stock | 13,774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000133 · edgar.xml · nonDerivative · entry 1 Lehr Donald P. · CIK 0001583187 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,957 F1 · price: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:08 UTC |
Bostick ThomasChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 75,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000134 · edgar.xml · derivative · entry 2 Bostick Thomas · CIK 0001724193 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,758 Underlying: Common Stock · 75,758 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:08 UTC |
Bostick ThomasChief Operating Officer
|
GrantCommon Stock | 13,774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000134 · edgar.xml · nonDerivative · entry 1 Bostick Thomas · CIK 0001724193 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,820 F1 · price: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:07 UTC |
Perez Jeffrey ThomasSVP, IP Affairs
|
GrantRestricted Stock Units · Derivative | 75,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000131 · edgar.xml · derivative · entry 2 Perez Jeffrey Thomas · CIK 0001617812 · SVP, IP Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,758 Underlying: Common Stock · 75,758 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:07 UTC |
Perez Jeffrey ThomasSVP, IP Affairs
|
GrantCommon Stock | 13,774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000131 · edgar.xml · nonDerivative · entry 1 Perez Jeffrey Thomas · CIK 0001617812 · SVP, IP Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,563 F1 · price: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:07 UTC |
Sabzevari HelenPresident, Precigen, Inc.
|
GrantRestricted Stock Units · Derivative | 13,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000130 · edgar.xml · derivative · entry 2 Sabzevari Helen · CIK 0001724195 · President, Precigen, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,775 Underlying: Common Stock · 13,775 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:07 UTC |
Sabzevari HelenPresident, Precigen, Inc.
|
GrantCommon Stock | 13,774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000130 · edgar.xml · nonDerivative · entry 1 Sabzevari Helen · CIK 0001724195 · President, Precigen, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,306 F1 · price: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:06 UTC |
Reed Thomas D.Chief Science Officer
|
GrantRestricted Stock Units · Derivative | 75,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000128 · edgar.xml · derivative · entry 2 Reed Thomas D. · CIK 0001583188 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,758 Underlying: Common Stock · 75,758 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:06 UTC |
Reed Thomas D.Chief Science Officer
|
GrantCommon Stock | 13,774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000128 · edgar.xml · nonDerivative · entry 1 Reed Thomas D. · CIK 0001583188 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,311 F1 · price: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:07 UTC |
Nimrodi NirChief Business Officer
|
GrantRestricted Stock Units · Derivative | 75,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000129 · edgar.xml · derivative · entry 3 Nimrodi Nir · CIK 0001602806 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,758 Underlying: Common Stock · 75,758 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:07 UTC |
Nimrodi NirChief Business Officer
|
GrantCommon Stock | 13,774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000129 · edgar.xml · nonDerivative · entry 1 Nimrodi Nir · CIK 0001602806 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,482 F1 · price: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:06 UTC |
Sterling Rick L.Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 75,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000127 · edgar.xml · derivative · entry 2 Sterling Rick L. · CIK 0001583123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,758 Underlying: Common Stock · 75,758 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:06 UTC |
Sterling Rick L.Chief Financial Officer
|
GrantCommon Stock | 13,774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000127 · edgar.xml · nonDerivative · entry 1 Sterling Rick L. · CIK 0001583123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,647 F1 · price: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:05 UTC |
Walsh Robert F. IIISVP, Energy & Fine Chem.
|
GrantRestricted Stock Units · Derivative | 75,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000126 · edgar.xml · derivative · entry 2 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,758 Underlying: Common Stock · 75,758 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. Read SEC document |
| January 04, 2019 Filed Jan 9, 2019 01:05 UTC |
Walsh Robert F. IIISVP, Energy & Fine Chem.
|
GrantCommon Stock | 13,774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000126 · edgar.xml · nonDerivative · entry 1 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,482 F1 · price: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation. Read SEC document |
| January 04, 2019 Filed Jan 22, 2019 23:07 UTC Amendment |
Walsh Robert F. IIISVP, Energy & Fine Chem.
|
GrantRestricted Stock Units · Derivative | 75,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000184 · edgar.xml · derivative · entry 2 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,758 Underlying: Common Stock · 75,758 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · shares: The number of derivative securities acquired was incorrectly reported as being disposed of in the report filed January 8, 2019. F4 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. F4 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. Read SEC document |
| January 04, 2019 Filed Jan 22, 2019 23:07 UTC Amendment |
Walsh Robert F. IIISVP, Energy & Fine Chem.
|
GrantCommon Stock | 13,774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000184 · edgar.xml · nonDerivative · entry 1 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,482 F1 · price: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 23:48 UTC |
Lehr Donald P.Chief Legal Officer
|
SaleCommon Stock | 3,832 | $7.07 | $27,094.16 |
DisclosureSEC source: 0001123292-19-000087 · edgar.xml · nonDerivative · entry 2 Lehr Donald P. · CIK 0001583187 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,183 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 23:48 UTC |
Perez Jeffrey ThomasSVP, IP Affairs
|
SaleCommon Stock | 3,514 | $7.07 | $24,845.74 |
DisclosureSEC source: 0001123292-19-000086 · edgar.xml · nonDerivative · entry 2 Perez Jeffrey Thomas · CIK 0001617812 · SVP, IP Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,789 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 23:47 UTC |
Reed Thomas D.Chief Science Officer
|
SaleCommon Stock | 2,944 | $7.07 | $20,815.55 |
DisclosureSEC source: 0001123292-19-000085 · edgar.xml · nonDerivative · entry 2 Reed Thomas D. · CIK 0001583188 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,537 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 23:46 UTC |
Sabzevari HelenPresident, Precigen, Inc.
|
SaleCommon Stock | 3,832 | $7.07 | $27,094.16 |
DisclosureSEC source: 0001123292-19-000084 · edgar.xml · nonDerivative · entry 2 Sabzevari Helen · CIK 0001724195 · President, Precigen, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,532 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 23:46 UTC |
Sterling Rick L.Chief Financial Officer
|
SaleCommon Stock | 3,514 | $7.07 | $24,845.74 |
DisclosureSEC source: 0001123292-19-000083 · edgar.xml · nonDerivative · entry 2 Sterling Rick L. · CIK 0001583123 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,873 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 23:46 UTC |
Walsh Robert F. IIISVP, Energy & Fine Chem.
|
SaleCommon Stock | 4,058 | $7.07 | $28,691.68 |
DisclosureSEC source: 0001123292-19-000082 · edgar.xml · nonDerivative · entry 2 Walsh Robert F. III · CIK 0001583727 · SVP, Energy & Fine Chem. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,708 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 23:45 UTC |
Nimrodi NirChief Business Officer
|
SaleCommon Stock | 4,058 | $7.07 | $28,692.09 |
DisclosureSEC source: 0001123292-19-000080 · edgar.xml · nonDerivative · entry 2 Nimrodi Nir · CIK 0001602806 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,708 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 18:46 UTC |
LIFFMAN JOEL DSVP, Finance
|
Exercise / conversionRestricted Stock Units · Derivative | 9,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000081 · edgar.xml · derivative · entry 3 LIFFMAN JOEL D · CIK 0001093734 · SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,297 Underlying: Common Stock · 9,766 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units were granted on January 2, 2018, and the remaining restricted stock units vest in three equal annual installments on each of January 2020, 2021 and 2022 F3 · derivative.expiration_date: The restricted stock units were granted on January 2, 2018, and the remaining restricted stock units vest in three equal annual installments on each of January 2020, 2021 and 2022 Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 18:46 UTC |
LIFFMAN JOEL DSVP, Finance
|
Exercise / conversionCommon Stock | 9,766 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000081 · edgar.xml · nonDerivative · entry 1 LIFFMAN JOEL D · CIK 0001093734 · SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:48 UTC |
Bostick ThomasChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 9,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000088 · edgar.xml · derivative · entry 2 Bostick Thomas · CIK 0001724193 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,297 Underlying: Common Stock · 9,766 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F2 · derivative.exercise_date: The restricted stock units were granted on January 2, 2018, and the remaining restricted stock units vest in three equal annual installments on each of January 2, 2020, 2021 and 2022. F2 · derivative.expiration_date: The restricted stock units were granted on January 2, 2018, and the remaining restricted stock units vest in three equal annual installments on each of January 2, 2020, 2021 and 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.